Table 1.
No significant demographic differences in CVID patients analyzed in the USIDNET registry
| No lung disease | Bronchiectasis | P value | ILD | P value | |
|---|---|---|---|---|---|
| Age at CVID diagnosisa (mean ± SD) | 30.6 ± 20.8 | 30.8 ± 19.6 | 30.3 ± 15.8 | ||
| Age of Symptom onsetb (mean ± SD) | 20.9 ± 19.9 | 17.7 ± 16.1 | 20 ± 15.8 | ||
| Male, n (%) | 490/1233 (39.7%) | 61 /147 (41.5%) | .69 | 55/138 (39.9%) | .98 |
| Hispanic ethnicityc, n (%) | 35/721 (4.9%) | 3/108 (2.8%) | .34 | 1/87 (1.1%) | .11 |
| Raced | |||||
| African American, n (%) | 25/1080 (2.3%) | 5/127 (3.9%) | .27 | 2/122 (1.6%) | .63 |
| Asian or Pacific Islander, n (%) | 8/1080 (0.7%) | 1/127 (0.8%) | .95 | 0/122 (0%) | .34 |
| Caucasian/White, n (%) | 1039/1080 (96.2%) | 117/127 (92.1%) | .03 | 119/122 (97.5%) | .46 |
| American Indian/Native American, n (%) | 2/1080 (0.2%) | 1/127 (0.8%) | .20 | 0/122 (0%) | .63 |
| Other or more than one race, n (%) | 6/1080 (0.6%) | 3/127 (2.4%) | .03 | 1/122 (0.8%) | .72 |
a
Age at CVID diagnosis was available for 81.1%, 80.3%, and 87.7% respectively of the no lung disease, bronchiectasis, and ILD group
b
Age of Symptom onset was available for 64.1%, 53.7%, and 73.2% respectively of the no lung disease, bronchiectasis, and ILD group
c
Ethnicity was known for 916 (60.3%) of the patients
d
Race was known for 1329 (87.5%) of the patients